Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-01 | New | $14,800,017 | $14,800,017 | Equity Only | 06b | SEC link |
| 2022-12-02 | New | $14,333,337 | $14,333,337 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Peter Flynn, Ph.D. | Director, Executive |
| Ed Hurwitz | Director |
| Jay Lichter, Ph.D. | Director |
| Tighe Reardon | Executive |
| Brian Slingsby, M.D., Ph.D., M.P.H. | Director |
| Ashish Xavier, Ph.D. | Director |